作者
Elise A. Olsen,Matthew Harries,Antonella Tosti,Wilma F. Bergfeld,Ulrike Blume‐Peytavi,Valerie D. Callender,Vasiliki Chasapi,Osvaldo Correia,George Cotsarelis,Rachita Dhurat,Ncoza C. Dlova,Isabella Doche,Nkechi Anne Enechukwu,Ramón Grimalt,Satoshi Itami,Maria Hordinsky,Kuzma Кhobzei,W. S. Lee,Subrata Malakar,Andrew G. Messenger,Amy Mcmichael,Paradi Mirmirani,Yuliya Ovcharenko,Sofia Papanikou,Giselle Martins Pinto,Bianca Maria Piraccini,Rodrigo Pirmez,P. Reygagne,Janet L. Roberts,Lidia Rudnicka,David Saceda‐Corralo,Jerry Shapiro,Tatiana Silyuk,Rodney Sinclair,Rui Oliveira Soares,A. Souissi,Annika Vogt,Ken Washenik,Abraham Zlotogorski,Douglas Canfield,Sergio Vañó‐Galván
摘要
Frontal fibrosing alopecia (FFA) has become one of the most common causes of cicatricial alopecia worldwide. However, there is a lack of clear aetiology and robust clinical trial evidence for the efficacy and safety of agents currently used for treatment.To enable data to be collected worldwide on FFA using common criteria and assessment methods.A multicentre, international group of experts in hair loss was convened by email to create consensus recommendations for clinical trials. Consensus was defined at > 90% agreement on each recommended part of these guidelines.Standardized diagnostic criteria, severity rating, staging, and investigator and patient assessment of scalp hair loss and other clinical features of FFA were created.These guidelines should allow the collection of reliable aggregate data on FFA and advance efforts in both clinical and basic research to close knowledge gaps in this condition.